Search results for " dienogest"

showing 2 items of 2 documents

Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?

2013

""The primary aim of the study was to analyze the endometrioma recurrence rate in patients who underwent laparoscopic excision followed by postoperative long-term regimen of oral contraceptives (OCs).. . MATERIALS AND METHODS: 168 patients who underwent a conservative laparoscopic surgery for endometrioma, during the period between September 2009 and August 2010 in three university hospitals were studied. A long-term OCs therapy was offered to all women following surgery. Patients were randomly divided into three groups according to different progestins used (desogestrel, gestodene, dienogest). Women who refused a postoperative hormonal therapy served as control. Follow-up visits and transv…

minimally invasive gynecologic surgeryAdultmedicine.medical_specialtyEndometriosis endometrioma recurrencee oral contraceptives minimally invasive gynecologic surgery progestins dienogest.AdolescentNorpregnenesendometrioma recurrenceeEndometriosisEndometriosisKaplan-Meier EstimateDrug Administration Schedulelaw.inventionYoung Adultchemistry.chemical_compoundRandomized controlled triallawSecondary PreventionHumansNandroloneMedicineIn patientOvarian DiseasesYoung adultLaparoscopyoral contraceptivesDesogestrelmedicine.diagnostic_testbusiness.industryObstetricsObstetrics and GynecologyEndometriosis Endometrioma recurrence Oral contraceptives Minimally invasive gynaecologic surgery Progestins DienogestGeneral MedicineLaparoscopic excisionmedicine.diseaseCombined Modality TherapySurgeryRegimenTreatment OutcomeDienogestchemistryprogestinsdienogestFemaleLaparoscopybusinessContraceptives OralFollow-Up Studies
researchProduct

Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis…

2015

Objectives To evaluate the efficacy of dienogest + estradiol valerate (E2V) and gonadotrophin-releasing hormone analogue (GnRH-a) in reducing recurrence of pain in patients with chronic pelvic pain due to laparoscopically diagnosed and treated endometriosis. Design Multi-center, prospective, randomized study. Setting Three university departments of obstetrics and gynecology in Italy. Population Seventy-eight women who underwent laparoscopic surgery for endometriosis combined with chronic pelvic pain. Methods Post-operative administration of dienogest + E2V for 9 months (group 1) or GnRH-a monthly for 6 months (group 2). Main outcome measures A visual analogue scale was used to test intensit…

Laparoscopic surgerymedicine.medical_treatmentEndometriosischronic pelvic painlaw.inventionGonadotropin-Releasing Hormonechemistry.chemical_compoundEndometriosis;dienogest;GnRH-analogue;pain recurrence;chronic pelvic painRandomized controlled triallawRecurrenceSurveys and QuestionnairesMedicineNandroloneSurveys and QuestionnaireProspective StudiesEndometriosiPain Measurementeducation.field_of_studyEstradiolMedicine (all)Estradiol valerateObstetrics and GynecologyGeneral MedicineMiddle Agedpain recurrenceDrug CombinationsDienogestItalyFemalemedicine.symptommedicine.drugHumanAdultmedicine.medical_specialtyAdolescentVisual analogue scalePopulationEndometriosisPelvic PainHumansPain ManagementEndometriosis GnRH-analogue chronic pelvic pain dienogest pain recurrence.educationGnRH-analoguebusiness.industryPelvic painmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaSurgeryProspective StudiechemistrydienogestQuality of LifeLaparoscopybusiness
researchProduct